ReviewMicroplastics and nanoplastics2025
Exposure scenarios for human health risk assessment of nano- and microplastic particles.
Review in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Polystyrene nanoplastics disrupt mouse placenta development in a sex-dependent manner.Reproductive toxicology (Elmsford, N.Y.) · 2026Article
- Exposure to Microplastics in Biological Matrices and Neurodevelopmental Outcomes in Children: A Systematic Review.Nanomaterials (Basel, Switzerland) · 2026Review
- Polystyrene microplastics and hepatic fibrosis-related indices in type 2 diabetes: a cross-sectional analysis with experimental validation.Particle and fibre toxicology · 2026Article
- Nanoplastics and Neurodegeneration: A Roadmap From Mechanism to Causation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Impact of Micro and Nanoplastics on Reproductive Cancer and the Potential Anticancer Benefits of Prolonged Ginger, Garlic, and Turmeric Consumption: A Narrative Review.International journal of environmental research and public health · 2026Review
- Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut-skin axis.Journal of translational medicine · 2026Review
- Active Antimicrobial Packaging Systems: Mechanisms of Microbial Control and Applications in Food Preservation.Biology · 2026Review
- Microplastics and child health: A scoping review of prenatal and early-life exposure routes and potential health risks.Toxicology reports · 2025Review
- Toxic threats from plastic waste: human health impacts, challenges, and policy solutions.RSC advances · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence of nano- and microplastic particles being present in the human body has increased in recent years, yet there is no acceptable methodology to perform a human health risk assessment for these particles because of limitations in the exposure and hazard assessments. Exposure assessment can be improved by establishing comprehensive and justifiable exposure scenarios for a defined exposure demographic, thoroughly describing the relevant exposure pathways, and performing multidimensional data alignment, thereby facilitating probabilistic estimates of nano- and microplastic particle exposure. General considerations of exposure scenarios are outlined, along with specifics details on the complexity and prioritization for nine demographic groups: adults; women; the elderly; individuals with disease; individuals employed in high-hazard occupations; and children demographics, including early infants, toddlers, school children, and teenagers. Recommendations to advance exposure assessments and scenarios are also provided which suggest: i) the use of well-defined exposure scenarios for demographics that are prioritized according to their level of complexity and concern; ii) a thorough description of relevant activity factors (physiological parameters, behavioural traits) and exposure factors (duration, frequency, media characterization) for the chosen demographic; iii) thorough descriptions of exposure via ingestion and inhalation, and in the case of early infants, including exposure via maternal transfer; iv) multidimensional data alignment and probabilistic methods to enable credible comparisons of exposure data across studies and inform physiologically based toxicokinetic models to estimate internal exposure. Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00134-9.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.